The coronavirus disease 2019 (COVID-19), an ongoing infectious disorder caused by acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is still incessantly spreading all around the world [1]. The inter-human transmission, principally conveyed by droplets or physical contact with infected biological material, has already caused the infection of millions people and the death of over 450,000 patients at the time of writing this editorial. With such an unprecedented clinical, societal and economic crisis, garnering timely and accurate information on COVID-19 is compulsory for avoiding mistakes and for taking the most appropriate medical and societal decisions [2].
The World Health Organization (WHO) is considered the leading worldwide association for prevention, containment and management of all human pathological conditions. This holds especially true at the times of COVID-19 pandemic, when every information provided by WHO officers will be taken for granted by billions people worldwide. It is hence objectionable that a lack of efficient communication could rapidly turn into a miscommunication, that may cause embarrassment for the whole Agency, and may especially enhance the risk of harm to the population, even fueling the debate of those who think that the use of preventive measures (such as the use of face mask) may be useless or even dangerous.
The specific circumstance is that of Maria Van Kerkhove, the WHO’s technical lead on the COVID-19 pandemic, who stated during a press conference on June 8, 2020, that asymptomatic transmission of SARS-CoV-2 is supposed to be “very rare” [3]. This information is obviously unreliable, as evidenced by a vast number of current clinical studies, which clearly show that the rate of asymptomatic SARS-CoV-2 transmission is “nothing but rare”. In a very recent article published in the journal “Science”, for example, Li et al. concluded that nearly 80% of SARS-CoV-2 infections might have been caused by asymptomatic individuals, either pre-symptomatic or fully asymptomatic throughout the entire course of their infection [4]. In another recently published article, which has reviewed the currently available scientific information on this matter, it has been reported that asymptomatic subjects may account for approximately 40–45% of SARS-CoV-2 infections, and that they can transmit the infection for as many as 14 days, thus concluding that asymptomatic transmission shall be regarded as a significant factor in the “rapid progression of COVID-19 pandemic” [5]. Notably, the rate of transmission of undocumented infections was also found to be nearly 1.6-fold higher than that of documented infections [4], thus strongly emphasizing that the risk of asymptomatic transmission may be bigger than that conveyed by symptomatic people. This is attributable to the facts that (i) asymptomatic and pre-symptomatic carriers of SARS-CoV-2 have a viral load that is ultimately comparable to that of symptomatic patients [6], and (ii) since asymptomatic and pre-symptomatic carriers are hardly undetectable, their isolation is almost unattainable, thus facilitating public circulation and amplifying the risk of virus spread.
Communicating medical information is not an always easy enterprise [7], especially at the times of COVID-19, when national governments, epidemiologists, healthcare professionals and administrators, as well as the general public, are eagerly willing to receive trustable guidance form reference health organizations, such as the WHO. We strongly advise that officers of eminent scientific organizations, agencies, associations and/or healthcare institutions must be very careful when communicating information and updates on COVID-19, because miscommunications and misunderstandings may otherwise enormously amplify the detrimental consequences of this already tragic pandemic.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
References
1. Lippi, G, Sanchis-Gomar, F, Henry, BM. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med 2020;8:497. https://doi.org/10.21037/atm.2020.03.157.Search in Google Scholar
2. Mattiuzzi, C, Lippi, G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020;8:48. https://doi.org/10.21037/atm.2020.02.06.Search in Google Scholar
3. Craven, J. WHO clarifies comments on asymptomatic transmission of SARS-CoV-2. Medscape 2020 Jun 3. Available from: https://www.medscape.com/viewarticle/932088. [Accessed 12 Jun 2020].Search in Google Scholar
4. Li, R, Pei, S, Chen, B, Song, Y, Zhang, T, Yang, W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 2020;368:489–93. https://doi.org/10.1126/science.abb3221.Search in Google Scholar
5. Oran, DP, Topol, EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med 2020 Jun 3. https://doi.org/10.7326/M20-3012 [Epub ahead of print].Search in Google Scholar
6. Chau, NVV, Thanh Lam, V, Thanh Dung, N, Yen, LM, Minh, NNQ, Hung, LM, et al. Clin Infect Dis 2020 Jun 4. https://doi.org/10.1093/cid/ciaa711. [Epub ahead of print]. PMID: 32497212.Search in Google Scholar
7. Negrini, D, Padoan, A, Plebani, M. Between web search engines and artificial intelligence: what side is shown in laboratory tests? Diagnosis (Berl) 2020 Apr 25. https://doi.org/10.01515/dx-2020-0022 [Epub ahead of print].Search in Google Scholar
© 2020 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorials
- COVID-19 or common coronavirus? A cautionary tale in advanced diagnostics
- Asymptomatic COVID-19 transmission: the importance of avoiding official miscommunication
- Reviews
- The optimal diagnostic methods for COVID-19
- COVID-19-associated coagulopathy
- Mini Reviews
- Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19)
- Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
- Opinion Papers
- COVID-19: making the right diagnosis
- Evolving oxygenation management reasoning in COVID-19
- Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?
- Original Articles
- Role of time-normalized laboratory findings in predicting COVID-19 outcome
- Anti SARS-CoV-2 antibodies monitoring in a group of residents in a long term care facility during COVID-19 pandemic peak
- Letters to the Editors
- The “Embrace Project”: facilitating the health care professionals in diagnosis, clinical reasoning and virtuous co-management of chronic patients before, during and after the COVID-19 pandemic in Italy
- False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations
- Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19)
Articles in the same Issue
- Frontmatter
- Editorials
- COVID-19 or common coronavirus? A cautionary tale in advanced diagnostics
- Asymptomatic COVID-19 transmission: the importance of avoiding official miscommunication
- Reviews
- The optimal diagnostic methods for COVID-19
- COVID-19-associated coagulopathy
- Mini Reviews
- Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19)
- Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
- Opinion Papers
- COVID-19: making the right diagnosis
- Evolving oxygenation management reasoning in COVID-19
- Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?
- Original Articles
- Role of time-normalized laboratory findings in predicting COVID-19 outcome
- Anti SARS-CoV-2 antibodies monitoring in a group of residents in a long term care facility during COVID-19 pandemic peak
- Letters to the Editors
- The “Embrace Project”: facilitating the health care professionals in diagnosis, clinical reasoning and virtuous co-management of chronic patients before, during and after the COVID-19 pandemic in Italy
- False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations
- Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19)